Drug Search Results
More Filters [+]


Alternative Names: mecamylamine, inversine, vecamyl
Latest Update: 2024-03-20
Latest Update Note: Clinical Trial Update

Product Description

Mecamylamine is a primary aliphatic amine. Mecamylamine has been used as a ganglionic blocker in treating hypertension, but, like most ganglionic blockers, is more often used now as a research tool. (Sourced from: https://pubchem.ncbi.nlm.nih.gov/compound/Mecamylamine)

Mechanisms of Action: nAChR Antagonist,AGB Blocker

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: Oral

FDA Designation: None *

Approval Status: Approved

Approved Countries: Ireland | Taiwan | United States

Approved Indications: None

Known Adverse Events: None

Company: None
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Mecamylamine

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases



Trial Status


Primary Completion Date

Probability of Success

Recent News Events